The first subsequent entry biologic authorized for market...

The first subsequent entry biologic authorized for market in Canada: The story of Omnitrope, a recombinant human growth hormone

Agnes V. Klein
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
39
Year:
2011
Language:
english
Pages:
4
DOI:
10.1016/j.biologicals.2011.06.003
File:
PDF, 227 KB
english, 2011
Conversion to is in progress
Conversion to is failed